TREATMENT OF EPILEPSY IN OUTPATIENT PEDIATRIC NEUROLOGY: CURRENT APPROACHES TO PHARMACOTHERAPY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Favorable pharmacokinetic profiles of antiepileptic drugs (AEDs) with linear kinetics, stable blood concentration, absence of clinically significant interactions with other drugs are important for the treatment of epilepsy in children and adolescents in the outpatient settings. Levetiracetam meets all these requirements. The study was aimed to the evaluation of the use of levetiracetam in outpatient neuropediatric practice. The study included 61 patients with various forms of epilepsy, including 31 girls and 30 boys between the ages of 2 and 17 years. 47 patients had concomitant diseases (neurological, somatic, endocrine), and this required particularly cautious approach for the selection of AEDs. Levetiracetam was administered in a therapeutic dose of 30 to 70 mg/kg/day. 23 (37.7%) children were on monotherapy; dual therapy was applied in 33 (54%) cases; and 5 (8.1%) children had received three AEDs. Positive clinical effect was achieved in 53 children - predominantly at 3 months of therapy, and in some cases already at 1-2 months of treatment, including slowing attacks by 25% in 2 children, by 50% - in 11, by 75% - in 3 children, and absence of seizures within 3-5 months in 38 (62.2%) children. Levetiracetam showed a high therapeutic efficacy, good tolerability, including in children and adolescents with comorbidity, so it has the advantage over other AEDs for use in outpatient neuropediatric practice.

Full Text

Restricted Access

About the authors

I. O Schederkina

MSBEIHPE RNSMU n.a. N.I. Pirogov of RMPH; Morozov Children's City Clinical Hospital of Moscow Healthcare Department

Email: sсhederkina@mail.ru
PhD, Associate Professor at the Department of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics, Neurologist at the Consultative Center of the Morozov Children's City Clinical Hospital of Moscow Healthcare Department

N. N Zavadenko

MSBEIHPE RNSMU n.a. N.I. Pirogov of RMPH; Morozov Children's City Clinical Hospital of Moscow Healthcare Department

Department of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics

A. N Zavadenko

Morozov Children's City Clinical Hospital of Moscow Healthcare Department

I. E Koltunov

Morozov Children's City Clinical Hospital of Moscow Healthcare Department

References

  1. Хаузер В.А. Описательная эпидемиология эпилепсии. В кн.: Современная эпилептология: проблемы и решения/ Под ред. Е.И. Гусева, А.Б. Гехт. М., 2015. C. 33-104.
  2. Карлов В.А. Эпилепсия у детей и взрослых, женщин и мужчин. М., 2010. 720 с.
  3. Shorvon S., Meieetkord H., Boon P., Göcke K., Shorvon S., Tinuper P., Holtkamp M. EFNS guideline on the management status epilepticus in adult. Eur. J. Neurology. 2010;3(17):348-55.
  4. Гузева В.И., Гузева В.В., Гузева О.В. Профилактика осложнений и оценка безопасности антиэпилептической терапии у детей. В кн.: Современная эпилептология: проблемы и решения/ Под ред. Е.И. Гусева,A.Б. Гехт. М., 2015. C. 471-89.
  5. Lyseng-Williamson K.A. Spotlight on levetiracetam in epilepsy. CNS Drugs. 2011; 25(10):901-5.
  6. Arzimanoglou A., Aicardi J. Эпилепсия и другие пароксизмальные расстройства. В кн.: Ж. Айкарди, М. Бакс, К. Гиллберг. Заболевания нервной системы у детей. Пер. с англ. / Под ред. А.А. Скоромца. М., 2013;2:644-738.
  7. Детская неврология. Клинические рекомендации. Выпуск 1 / Под ред. B.И. Гузевой. М., 2014. С. 265-327.
  8. Балакирева Е.А., Неретина А.Ф. О применении леветирацетама при эпилепсии у детей. Казанский медицинский журнал. 2009;90(5):641-44.
  9. Белоусова Е.Д. Рациональная политерапия эпилепсии у детей. Журнал неврологии и психиатрии им. С.С. Корсакова. 2014;114(4) вып.2:35-40.
  10. Перукка Э. Эпилепсия как излечимое заболевание мозга: проблемы и перспективы. В кн.: Современная эпилептология: проблемы и решения/ Под ред. Е.И. Гусева, А.Б. Гехт. М., 2015. С. 9-31.
  11. Eddy C.M., Rickards H.E., Cavanna A.E. The cognitive impact of antiepileptic drugs. Ther. Adv. Neurol. Disord. 2011;4(6):385-407.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies